Double Tympanocentesis Studies: Bridging from Bacteriological Outcome to Studies with Clinical Outcome

7/19/02


Click here to start


Table of Contents

Double Tympanocentesis Studies: Bridging from Bacteriological Outcome to Studies with Clinical Outcome

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

NTHi Eradication Rate: Amox/Clav (45mg/kg) vs. Azithromycin

Clinical Success: Amox/Clav (45mg/kg) vs. Azithromycin

Clinical Success: Amox/Clav (45mg/kg) vs. Azithromycin

PPT Slide

Study 1015 (Single Dose Azithro 30 mg/kg) Conducted by Pfizer by Penicillin Susceptibility

PPT Slide

Clinical Success in Studies Conducted by Pfizer by by Pathogens

PPT Slide

PPT Slide

Clinical Recurrence After Completion of Rx vs Bacteriologic Relapse

New Acquisition vs Persistence of Pathogens in Clinical Recurrence of AOM in Relation to Initial AOM Isolate*

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

Author: prof. Ron Dagan